Technology & Innovation· Pulse
Eli Lilly Just Paid $3.8 Billion to Bet That Depression's Next Blockbuster Looks Like DMT
Big Pharma didn't wait for psychedelic therapy to get easy, cheap, or fully de-risked. It just bought a seat at the table — the second nine-figure-plus deal in the sector in under a year.
Jul 31 · 2 minRead